Mark Bachman is listed as an executive officer, director, and promoter on 4 SEC Form D filings by 2 issuers between Dec 2014 and Aug 2016: Leafline Labs, LLC (Cottage Grove, MN — pharmaceuticals — 2014–2016; $14.9M reported sold to 141 investors) and GAIA Principal, LLC (Minneapolis, MN — industry reported as "Other" — 2016; $4.54M reported sold to 55 investors).
What this means 2 separate companies raised money with this person listed as executive officer, director, and promoter, over about 2 years. Across those companies the filings report $19.5M sold in total.
Listed alongside Andrew Bachman (3 shared filings), Ethan Ruby (3 shared filings), Gary Starr (3 shared filings), Glenn Taylor (3 shared filings), Kelly Henry (3 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Mark. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 5 bankruptcy cases matching the name listed in Key records below.
What this means 5 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Mark Bachman and found 7 differences, 2 worth asking the sponsor about: Form D filed 105 days after the first sale; Mark Bachman is no longer listed on the Aug 2, 2017 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.